Mark H. Pavao

Fundador en R-Pharm US LLC .

Health Technology

Perfil

Mark H.
Pavao is the founder of R-Pharm US LLC, which was founded in 2014.
He held the title of Director at the time of founding.
Mr. Pavao's former job was Senior Vice President-Sales & Marketing at NitroMed, Inc.

Cargos activos de Mark H. Pavao

Empresas	Cargo	Inicio
R-Pharm US LLC R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ.	Fundador	01/01/2014

Todos los cargos activos de Mark H. Pavao

Antiguos cargos conocidos de Mark H. Pavao.

Empresas	Cargo	Fin
NitroMed, Inc. NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA.	Ventas & Marketing	-

Ver el detalle de la experiencia de Mark H. Pavao.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mark H. Pavao.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
NitroMed, Inc. NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA.	Health Technology
R-Pharm US LLC R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ.	Health Technology

Ver las conexiones de la empresa